Ultrahuman Ring Pro Lands in the US at $479
TL;DR
Ultrahuman just proved that the no-subscription, on-device health tracking model is commercially viable at scale. They also proved it at a price that leaves room for exactly one cheaper competitor. Pulsyn is that competitor at $160. The difference between $479 and $160 is not a discount. It is a statement about margins, architecture, and who gets to profit from your heartbeat.
The customs block and why it lasted this long
Gizmodo published a story yesterday that most smart ring buyers will miss entirely. Ultrahuman Ring Pro, blocked at the US border for months by an Oura patent dispute, finally cleared customs. It is now on sale in America at $479 with no subscription. That last sentence is the only one that matters.
The patent block was not a shipping delay. It was a strategic attempt by Oura to keep a direct competitor out of the largest wearable market on Earth. Oura filed suit at the International Trade Commission claiming Ultrahuman infringed on ring design patents. The ITC sided with Oura initially, which meant Ultrahuman could not import its hardware into the US. Months of legal back-and-forth followed. Then, last week, the block lifted. CNET, Digital Trends, and Gizmodo all ran stories within 24 hours. The coverage was glowing.
What none of the coverage fully explains is why Oura fought this so hard. Oura is not scared of another $350 ring. Oura is scared of a $479 ring that does not charge $72 per year. Subscription revenue is the entire reason Oura filed for IPO in May 2026. Hardware is the acquisition cost. The subscription is the profit. Ultrahuman threatens that model more than any hardware clone because it removes the recurring revenue entirely. Oura knew this. The ITC case was never about ring shape. It was about business model defense.
What $479 buys you, and what it does not
Ultrahuman Ring Pro costs $479. For that, you get a titanium smart ring with sleep tracking, heart rate monitoring, SpO2, skin temperature, stress scoring, and activity metrics. The data stays on the ring for 250 days before you need to sync. The ML runs on-device, not in a cloud. There is no monthly fee. There is no annual plan. You buy the ring and you own the tracking.
On paper, this is almost exactly what Pulsyn is building. The difference is price. Ultrahuman charges $479. Pulsyn will charge $160 at Kickstarter and $200 at retail. That $319 gap is not a sale. It is a fundamentally different view of what this product should cost.
To understand why, look at the competitive set. Oura Ring 4 is $349 plus $72 per year. Over three years, an Oura owner pays $565. A Whoop member pays $30 per month with no device purchase option, which is $1,080 over three years. Fitbit Premium is $9.99 per month on top of hardware that already costs $229 to $299. Apple Watch does not require a subscription for basic health tracking, but the device starts at $399 and the battery barely lasts a day.
Ultrahuman at $479 is cheaper than Oura over a two-year horizon, more expensive than Pulsyn by a factor of three, and cheaper than Whoop by half. The pricing is deliberate. Ultrahuman is positioning itself as the premium no-subscription option. They are not trying to undercut Oura on hardware. They are trying to outflank Oura on business model while keeping the prestige price tag.
This leaves a strange hole in the market. There is now a $75 Pebble ring at the bottom, a $479 Ultrahuman ring at the top, and a $349 Oura ring in the middle that charges $72 per year. The hole is a $160 ring that does everything the $479 ring does without the titanium markup or the brand premium. That hole is where Pulsyn lives.
Why the price is the real story
I wrote about smart ring hardware margins last week. The bill of materials for a ring with BLE, PPG sensors, an accelerometer, a temperature sensor, and a small lithium cell is roughly $30 at volume. The charging case adds maybe $8. Packaging and assembly might push the total landed cost to $45 or $50. Anything above that is margin, marketing, or legal defense.
At $479, Ultrahuman is taking roughly a 90% gross margin. That is not a criticism. That is standard for consumer electronics. Apple does it. Dyson does it. Oura does it. The question is what the margin pays for.
Oura uses its margin to fund a subscription app, a cloud infrastructure, a data science team, and now an IPO roadshow. Ultrahuman uses its margin to fund on-device ML research, titanium casings, and a legal team that can survive an ITC blockade. Pulsyn uses its margin to fund a smaller team, on-device AI, and a manufacturing run that does not require venture capital to close.
The margin difference between $479 and $160 is roughly $300 per unit. That $300 represents two things: brand premium and cost structure. Ultrahuman has a brand it built in Europe and Asia before the US block. It has a team of dozens. It has retail partnerships. Those things cost money. Pulsyn has none of that yet. We are one founder, a prototype, and a Kickstarter page. Our cost structure is lower because our overhead is lower, not because our hardware is worse.
This is the part that gets lost in reviews. Tech journalists compare feature lists. They do not compare burn rates. Ultrahuman and Pulsyn both run ML on-device. Both store data locally. Both skip the subscription. But Ultrahuman needs to sell at $479 to make the math work for its organization. Pulsyn can sell at $160 because the organization is smaller, the fundraising target is lower, and the goal is unit volume over brand premium.
The reputation gap that price cannot fix
Here is where I need to be honest about something that matters more than specs.
Ultrahuman has a reputation problem on Reddit. Search r/SmartRings or r/RingConn and you will find threads with titles like "DO NOT I REPEAT DO NOT BUY AN ULTRAHUMAN RING" and "Really regretting my Ultrahuman purchase." The complaints cluster around three issues: rings bricking after firmware updates, support ghosting customers for weeks or months, and refund requests vanishing into automated ticketing systems.
I am not saying every Ultrahuman customer has a bad experience. I am saying the signal-to-noise ratio on user satisfaction is lower than the $479 price suggests it should be. When you charge premium prices, buyers expect premium support. Ultrahuman has not consistently delivered that. The Gizmodo review calling it "the best smart ring you have never heard of" does not mention the 45-day refund window that some users say never materializes.
Price is a promise. At $479, the promise is that this product is better than the $349 alternative. Better materials, better software, better service. If the service layer breaks, the price becomes evidence of betrayal. Oura is learning this now with its support crisis. Ultrahuman will learn it too if the US launch generates volume before the support infrastructure is ready.
Pulsyn has no support reputation yet because we have no customers yet. That is a vulnerability and an opportunity. We are building the support pipeline now, before the Kickstarter, with the assumption that every early backer becomes either a referrer or a warning. The $160 price sets expectations lower than $479, which is an advantage. A $160 ring that works and gets answered emails beats a $479 ring that bricks and ghosts.
What this launch means for Pulsyn
Ultrahuman entering the US market at $479 is the best thing that could happen to Pulsyn before our Kickstarter in Q2 2026. Here is why.
First, it validates the no-subscription model in the minds of American consumers. Until now, the only no-subscription option with any US presence was RingConn, and RingConn is currently dealing with burn injuries, battery failures, and a messy app redesign. Ultrahuman is a real brand with real marketing budget telling US buyers that subscriptions are optional. That educates the market for us.
Second, it creates a price umbrella. Pulsyn at $160 is now the budget option in a validated premium category. That is a much easier sell than being the cheap option in a category nobody believes in. When Ultrahuman spends marketing dollars explaining why on-device ML is worth $479, Pulsyn gets to say the same thing for $160. We are not discounting a premium product. We are selling the same architecture with fewer overheads.
Third, it puts pressure on Oura at exactly the wrong moment. Oura just filed for IPO. Its S-1 document reveals that subscription revenue is the growth engine and that churn is rising. The appearance of a credible no-subscription competitor at $479, combined with Pebble's $75 Index 01 at the bottom end, squeezes Oura from both directions. Pulsyn sits in the middle: more capable than Pebble, more affordable than Ultrahuman, and more trustworthy than Oura.
Fourth, it sets a deadline. Ultrahuman is shipping now. Pebble is shipping now. Oura is entrenched. By Q3 2026, when Pulsyn retails, the market will have three established players. We are not entering a vacuum. We are entering a war, and our advantage is that we built for this exact conditions from day one. No subscription was not a marketing angle for us. It was an architectural decision made before the first circuit board was ordered.
The honest part
I want to end with something I am not sure about.
Ultrahuman has been building rings longer than Pulsyn has existed. They have shipped hardware to actual customers on multiple continents. They have a manufacturing partner, a logistics chain, and a legal team that survived an ITC blockade. I have a prototype, a 3D printer, and a spreadsheet.
The $160 price assumes we can hit our COGS target of $30 at a 500-unit production run. That assumption depends on a Shenzhen manufacturer we have not visited yet and a resin printer we have not bought yet. If the printer warps the charging case molds or the manufacturer raises minimum order quantities, the $160 price could become $180 or $200. That would still undercut Ultrahuman by $279, but it would change the story.
I am also not sure if the US market will care about on-device processing by Q3 2026. Right now, privacy scandals and subscription fatigue are peaking. That could fade. A new iPhone feature could swallow the conversation. Regulatory pressure could force Oura to offer a no-subscription tier, blurring the differentiation. We are betting that the trend toward local-first data is structural, not cyclical. That bet could be wrong.
What I do know is this: Ultrahuman just spent months in court and millions in legal fees to sell a $479 ring with no subscription. They would not do that if the model were a gimmick. They would not do that if the market were imaginary. The no-subscription smart ring is real. The only question left is what it should cost. Pulsyn says $160. We will find out in Q2 2026 if we are right.
About the author
James Hoffmann is the founder of Pulsyn. He has been reverse-engineering BLE health devices and evaluating wearable supply chains for two years.
References
- Gizmodo, May 2026: "The Best Smart Ring You've Never Heard of Has Finally Cleared U.S. Customs" (Ultrahuman Ring Pro coverage)
- CNET, May 2026: "Ultrahuman, Oura's Biggest Rival, Returns to the US With Its New Ring Pro"
- Digital Trends, May 2026: "Ultrahuman Ring PRO is back in the US, and it makes every other smart ring look overpriced"
- r/SmartRings, May 2026: User threads on Ultrahuman support experiences and refund issues
- Pulsyn internal trend scan, May 26 2026: r/ouraring battery degradation and electrical shock complaint threads
